Andra AP fonden acquired a new position in Teleflex Incorporated (NYSE:TFX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,300 shares of the medical technology company’s stock, valued at approximately $1,833,000.
Several other hedge funds have also recently made changes to their positions in the business. Janus Henderson Group PLC raised its position in shares of Teleflex by 2.8% in the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock worth $1,329,704,000 after acquiring an additional 147,147 shares in the last quarter. State Street Corp raised its position in shares of Teleflex by 1.0% in the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock worth $508,757,000 after acquiring an additional 21,291 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Teleflex by 0.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,130,560 shares of the medical technology company’s stock worth $278,676,000 after acquiring an additional 5,746 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Teleflex by 0.4% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 427,579 shares of the medical technology company’s stock worth $105,749,000 after acquiring an additional 1,884 shares in the last quarter. Finally, Point72 Asset Management L.P. raised its position in shares of Teleflex by 31.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 407,442 shares of the medical technology company’s stock worth $100,768,000 after acquiring an additional 96,958 shares in the last quarter. 95.62% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several analysts have recently commented on TFX shares. Royal Bank of Canada downgraded Teleflex from an “outperform” rating to a “sector perform” rating and reduced their target price for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Morgan Stanley reduced their target price on Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research note on Wednesday, March 5th. StockNews.com downgraded Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. Wells Fargo & Company reduced their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating for the company in a research note on Friday, February 28th. Finally, Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $182.63.
Teleflex Price Performance
TFX stock opened at $140.24 on Monday. The company has a market capitalization of $6.50 billion, a P/E ratio of 27.88, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 52-week low of $128.55 and a 52-week high of $249.90. The business has a 50-day simple moving average of $171.13 and a two-hundred day simple moving average of $201.04.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Research analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.
Teleflex Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, March 7th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.97%. Teleflex’s payout ratio is presently 95.77%.
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Articles
- Five stocks we like better than Teleflex
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- What is a buyback in stocks? A comprehensive guide for investors
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.